Advertisement

Pediatrics

Resource Center

News
Research Summaries
Resources
FDA Alerts Pearls of Wisdom From the Journal
Insights
Commentary Podcasts Q&As Videos
Interactive
Polls Quizzes Slideshows
Events & Education

FDA Alerts

FDA Alert
fda alerts
FDA Alert
As Infections Increase, FDA Approves Updated Vaccines to Protect Against COVID-19 Variants
09/15/2023

Anthony Calabro, MA

Anthony Calabro, MA
The FDA approved the new round of vaccines for those 12 and older and authorized emergency use for children 6 months to 11 years of age.
09/15/2023
FDA Alert
fda
FDA Alert
FDA Approves First RSV Vaccine For Pregnant Individuals
08/24/2023

Anthony Calabro, MA

Anthony Calabro, MA
Earlier this year, the FDA approved the same vaccine for the prevention of lower respiratory tract disease caused by RSV in individuals 60 years of age and older.
08/24/2023
FDA Alert
FDA Alert
FDA Alert
FDA Approves Two Medications to Treat Pediatric Patients With Type 2 Diabetes
08/10/2023

Jessica Ganga

Jessica Ganga
The FDA has approved empagliflozin, and empagliflozin and hydrochloride to help manage type 2 diabetes in pediatric patients.
08/10/2023
FDA Alert
vaccine
FDA Alert
FDA Approves First Monoclonal Injection to Prevent RSV in Infants, Toddlers
07/24/2023

Jessica Ganga

Jessica Ganga
Following three clinical trials, the FDA has approved a new preventive treatment for neonates, infants, and toddlers that prevents respiratory syncytial virus (RSV) in those age populations.
07/24/2023
FDA Alert
Child holding stomach
FDA Alert
First Treatment for Pediatric Functional Constipation Approved by FDA
06/15/2023

Jessica Ganga

Jessica Ganga
The FDA approved the first treatment for pediatric patients who experience functional constipation
06/15/2023
FDA ALERT
medication
FDA ALERT
FDA Approves First Treatment for Rare, Degenerative Disease
04/18/2023

Jessica Ganga

Jessica Ganga
The FDA has approved a treatment for Friedreich ataxia after the results of randomized, placebo-controlled study indicate a strong effectiveness in treatment.
04/18/2023
Enzyme Replacement Therapy
Enzyme Replacement Therapy
First Enzyme Replacement Therapy to Treat Rare Genetic Disorder Approved
03/17/2023

Jessica Ganga

Jessica Ganga
Following a multicenter study, the FDA has approved the first enzyme replacement therapy in the United States to treat alpha-mannosidosis.
03/17/2023
Treatment
Treatment
FDA Approves First Treatment for Active Psoriatic Arthritis in Pediatric Patients
08/23/2022
The US Food and Drug Administration has approved a new treatment for pediatric patients with active psoriatic arthritis.
08/23/2022
Pediatrics
Pediatrics
FDA Approves New ADHD Treatment Option for Children
04/07/2021
The US Food and Drug Administration has approved a new nonstimulant drug for the treatment for attention-deficit/hyperactivity disorder in children.
04/07/2021
Pediatrics
Pediatrics
FDA Approves First Video Game-Based Treatment for ADHD
06/17/2020
The US Food and Drug Administration has approved the marketing of the first video game-based digital therapeutic device for the treatment of children aged 8 to 12 years with attention deficit hyperactivity...
06/17/2020